🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fun times in Milan 🇮🇹- visiting 🍷🍝, catching up with friends, making new ones, and a little time to talk #ergonomics. Thanks everyone for the welcome! Dario Callegaro Istituto Tumori Stefano Partelli Università Vita-Salute San Raffaele

Starting our discussion with Thor Halfdanarson – (Q1) what is Peptide Receptor Radionuclide Therapy (PRRT)? #ASOchat

Julie Hallet from U of T Department of Surgery continues the "surgical outcomes" theme this morning with some insights into the importance of shared decision making #ALPS2025 IHPBA

A huge thank you to European Society of Surgical Oncology (ESSO) & Society of Surgical Oncology for the incredible opportunity as 2024s ICDE recipient! It was an unforgettable experience visiting Ospedale San Raffaele 🇮🇹 where I had the privilege of working with the best in the field #HPBSurg #NETs 🦓 #Grateful Stefano Partelli Nicolò Pecorelli

The Identity Card of CUTNETs Group 🦓🔪collaboration is out on BJS 🇨🇦 🇺🇸 🇪🇺 Julie Hallet

Help us reach consensus ✍️ OHSU Knight Cancer Institute

🦓 On NEJM - Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors #neuroendocrineTumors nejm.org/doi/full/10.10…

Excited to announce our NIH-funded SWOG trial activates today! S2408 will study whether a single dose of lanreotide can reduce pancreas leak.💉🚫💧 Thanks to all who helped get us here! Syed A. Ahmad Paul Karanicolas Sepideh Gholami, MD, MAS, FACS, FSSO Flavio G Rocha, MD, FACS, FSSO SWOG Cancer Research Network The Hope Foundation for Cancer Research

If you needed a reminder of the poor outcomes of patients with NECs, here you go. The current approach of platinum/etoposide yields the same disappointing results as in prior studies and outcomes of 2nd line therapy are poor. Better therapy sorely needed. link.springer.com/article/10.100…

Cristina Scielzo from Cristina Scielzo LAB Ospedale San Raffaele presenting at #ENETS2025 on 3D bioprinting reconstruction of the tumor microenvironment in vitro🔬🧪 Innovative models to study pancreatic NET biology and therapy responses.ENETS NET Research Foundation NANETS Anna Battistella

Because you can resect does not mean you should Not all NETs are the same Stefano Partelli introducing biological unresectability for PNETs at #ENETS25 👉🏻 identifying futile surgery & when preop therapy will help We have 💊options - let’s figure out how to combine with surgery!

🏆 Life Achievement Award for Prof. Ruszniewski, a living legend in the NET field! A remarkable leader of a fantastic team of doctors, researchers, and, above all, friends. Merci, Philippe! #ENETS2025 ENETS

Highlights from the 22nd European Neuroendocrine Tumor Society (ENETS) Conference The 22nd Annual ENETS Conference took place from March 5–7 in Krakow, Poland. Stefano Partelli Udhayvir Grewal Angela Lamarca Thor Halfdanarson Rachel Riechelmann Julie Hallet FRANCESCA SPADA

Bye Krakow! You’ve been great! 😃 It was a productive #ENETS25 of learning about my favourite topic with ⭐️ colleagues & friends, and more opportunities to build CUTNETs Group 🦓🤝 to create better care for our patients 🆙 See you next year, same place, same time 🇵🇱

Yesterday my student Matilda Roos-Mattila defended her thesis on ”Stromal Inflammatory Markers and Drug Sensitivities in Pancreatic Malignancies” with potential help for PDAC patients (stay tuned). Prestige opponent prof Johanna Ivaska ⁦Johanna Ivaska⁩

🔹 Another fantastic European Society of Surgical Oncology (ESSO) surgical anatomy course on #PancreaticCancer successfully completed! 🔹 This time in a new location: Hamburg ! 🇩🇪✨ A big thank you to #ThiloHackert and #FelixNickel for hosting us, and to the amazing faculty Elena Rangelova , Ville Sallinen ,